| C08CA13 |
Lercanidipine |
ARETA |
Film coated tablet |
20 |
mg |
30 |
Stada Arzneimittel AG, Германия |
10 |
mg |
10.14 |
- |
0.15833 |
9.5 |
100% |
9.5 |
|
I10 |
HCP-8817/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
2781 |
| C08CA13 |
Lercanidipine |
ARETA |
Film coated tablet |
10 |
mg |
30 |
Stada Arzneimittel AG, Германия |
10 |
mg |
8.06 |
- |
0.15833 |
4.75 |
100% |
4.75 |
|
I10 |
HCP-8817/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
2364 |
| C08CA13 |
Lercanidipine |
Caniler |
Film coated tablet |
20 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
9.95 |
- |
0.15833 |
9.5 |
100% |
9.5 |
|
I10 |
HCP-8821/13.04.2016.; КП-133/06.11.2017 и НСП-13163/17.07.2017.; АССГ № 531/29.01.2018 и ВАС № 7806/12.06.2018 |
02.08.2019 |
|
|
Активен |
4137 |
| C08CA13 |
Lercanidipine |
Caniler |
Film coated tablet |
10 |
mg |
30 |
Sandoz d.d., Словения |
10 |
mg |
4.75 |
- |
0.15833 |
4.75 |
100% |
4.75 |
|
I10 |
HCP-8821/13.04.2016.; КП-98/25.10.2017 и НСП-13162/17.07.2017. |
02.08.2019 |
|
|
Активен |
4136 |
| C08CA13 |
Lercanidipine |
Kapidin |
Film coated tablet |
20 |
mg |
30 |
Zentiva k.s., Чешка република |
10 |
mg |
10.85 |
- |
0.15833 |
9.5 |
100% |
9.5 |
|
I10 |
HCP-8818/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1573 |
| C08CA13 |
Lercanidipine |
Kapidin |
Film coated tablet |
10 |
mg |
30 |
Zentiva k.s., Чешка република |
10 |
mg |
4.75 |
- |
0.15833 |
4.75 |
100% |
4.75 |
|
I10 |
HCP-8818/13.04.2016; НСР-13399/04.08.2017 |
02.08.2019 |
08.09.2012 |
|
Активен |
3752 |
| C08CA13 |
Lercanidipine |
Lecalpin |
Film coated tablet |
20 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
10 |
mg |
9.95 |
- |
0.15833 |
9.5 |
100% |
9.5 |
|
I10 |
HCP-8816/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
3008 |
| C08CA13 |
Lercanidipine |
Lecalpin |
Film coated tablet |
10 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
10 |
mg |
5.98 |
- |
0.15833 |
4.75 |
100% |
4.75 |
|
I10 |
HCP-8816/13.04.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
3115 |
| C08CA13 |
Lercanidipine |
Lercanicon |
Film coated tablet |
10 |
mg |
30 |
Фармаконс АД, България |
10 |
mg |
9.5 |
- |
0.11833 |
3.55 |
100% |
3.55 |
|
I10 |
НСР-17011/19.10.2018 |
02.08.2019 |
|
|
Активен |
15841 |
| C08CA13 |
Lercanidipine |
Renovia |
Film coated tablet |
20 |
mg |
60 |
Berlin - Chemie AG, Германия |
10 |
mg |
23.63 |
- |
0.15833 |
19 |
100% |
19 |
|
I10 |
НСР-14444/17.11.2017 |
02.08.2019 |
|
|
Активен |
15932 |
| C08CA13 |
Lercanidipine |
RENOVIA |
Film coated tablet |
10 |
mg |
60 |
Berlin-Chemie AG (Menarini Group), Германия |
10 |
mg |
14.47 |
- |
0.15833 |
9.5 |
100% |
9.5 |
|
I10 |
HCP-8819/13.04.2016.; HCP-9493/09.06.2016. |
02.08.2019 |
08.09.2012 |
|
Активен |
1033 |
| C08CA13 |
Lercanidipine |
TevaLer |
Film coated tablet |
10 |
mg |
30 |
Teva B.V., Нидерландия |
10 |
mg |
7.75 |
- |
0.15833 |
4.75 |
100% |
4.75 |
|
I10 |
HCP-8820/13.04.2016.; НСР-17414/06.12.2018. |
02.08.2019 |
|
|
Активен |
1937 |
| C08CA13 |
Lercanidipine |
TevaLer |
Film coated tablet |
20 |
mg |
30 |
Teva B.V., Нидерландия |
10 |
mg |
11.3 |
- |
0.15833 |
9.5 |
100% |
9.5 |
|
I10 |
HCP-8820/13.04.2016; КП-90/30.10.2018 и НСР-16742/07.09.2018; НСР-17415/06.12.2018. |
02.08.2019 |
|
|
Активен |
1936 |
| C08DA01 |
Verapamil Hydrochloride |
C08DA01 Verapamil Hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C08DA01 |
Verapamil |
Isocor |
Film coated tablet |
80 |
mg |
30 |
Софарма АД, България |
240 |
mg |
- |
2.3 |
0.23 |
2.3 |
25% |
0.58 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-18082/01.03.2019 |
02.04.2019 |
08.09.2012 |
|
Заличен |
180 |
| C08DA01 |
Verapamil |
Isoptin |
Film coated tablet |
80 |
mg |
50 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
6.71 |
0.23035 |
3.84 |
25% |
0.96 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-3796/16.06.2014; КП-43/05.03.2015 и НСР-3327/24.04.2014; пром.на обстоят.НСР-8196/22.02.2016; НСР-9613/23.06.2016 и КП-102/29.08.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
3655 |
| C08DA01 |
Verapamil |
Isoptin |
Film coated tablet |
40 |
mg |
50 |
Abbott GmbH & Co KG, Германия |
240 |
mg |
- |
3.88 |
0.23 |
1.92 |
25% |
0.48 |
|
I10,I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-7138/24.09.2015 |
16.10.2015 |
08.09.2012 |
|
Заличен |
451 |
| C08DA01 |
Verapamil |
Isoptin SR |
Prolonged release tablet |
240 |
mg |
50 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
25.85 |
0.23035 |
11.52 |
25% |
2.88 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-3798/16.06.2014; пром.на обстоят.НСР-8197/22.02.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
452 |
| C08DA01 |
Verapamil |
Isoptin SR |
Prolonged release tablet |
120 |
mg |
20 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
5.04 |
0.23035 |
2.3 |
25% |
0.57 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
КЦРР-884/28.06.2012 г.; НСР-3797/16.06.2014; пром.на обстоят.НСР-8198/22.02.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
1279 |
| C08DA01 |
Verapamil |
Isoptin SR |
Prolonged release tablet |
240 |
mg |
20 |
Mylan Healthcare GmbH, Германия |
240 |
mg |
- |
8.64 |
0.23035 |
4.61 |
25% |
1.15 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
КЦРР-560/04.05.2012 г.; НСР-3802/16.06.2014; КП-74/06.03.2015 и НСР-23.07.2014; пром.на обстоят.НСР-8199/22.02.2016; НСР-9637/23.06.2016 и КП-103/29.08.2016 |
02.04.2019 |
08.09.2012 |
|
Активен |
3668 |
| C08DA01 |
Verapamil |
Verapamil Actavis |
Prolonged release tablet |
120 |
mg |
50 |
Актавис EАД, България |
240 |
mg |
- |
5.76 |
0.23 |
5.75 |
25% |
1.44 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
|
02.08.2016 |
08.09.2012 |
|
Заличен |
250 |
| C08DA01 |
Verapamil |
Verapamil Sopharma |
Film coated tablet |
40 |
mg |
50 |
Софарма АД, България |
240 |
mg |
- |
2.99 |
0.23035 |
1.92 |
25% |
0.48 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
|
02.04.2019 |
08.09.2012 |
|
Активен |
179 |
| C08DA01 |
Verapamil |
Verapamil Sopharma |
Film coated tablet |
80 |
mg |
50 |
Софарма АД, България |
240 |
mg |
- |
3.84 |
0.23035 |
3.84 |
25% |
0.96 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
№35/21.08.2009; НСР-17489/13.12.2018 |
02.04.2019 |
08.09.2012 |
16.11.2013 |
Активен |
126 |
| C08DA01 |
Verapamil |
Verapamil-Tchaikapharma |
Coated tablet |
80 |
mg |
50 |
Чайкафарма Висококачествените лекарства АД, България |
240 |
mg |
- |
4.24 |
0.23035 |
3.84 |
25% |
0.96 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-2956/07.03.2014; НСР-18346/05.04.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
2605 |
| C08DA01 |
Verapamil |
Verapamil-Tchaikapharma |
Coated tablet |
40 |
mg |
30 |
Чайкафарма Висококачествените лекарства АД, България |
240 |
mg |
- |
2.3 |
0.23035 |
1.15 |
25% |
0.28 |
|
I11.9,I12.9,I13.1,I20.1,I20.8,I20.9,I45.6,I47.1,I48 |
НСР-2494/24.01.2014; НСР-3160/26.03.2014; КП-51/21.06.2018 и НСР-15498/26.04.2018 |
02.04.2019 |
08.09.2012 |
|
Активен |
2533 |